Douglas B Given - Net Worth and Insider Trading
Douglas B Given Net Worth
The estimated net worth of Douglas B Given is at least $3 Million dollars as of 2024-04-24. Douglas B Given is the Director of Arrowhead Pharmaceuticals Inc and owns about 129,711 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $3 Million. Details can be seen in Douglas B Given's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Douglas B Given has not made any transactions after 2024-01-11 and currently still holds the listed stock(s).
Transaction Summary of Douglas B Given
Douglas B Given Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas B Given owns 3 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) , VIA Pharmaceuticals Inc (VIAP) , and Aksys Ltd (AKSY) .
Click here to see the complete history of Douglas B Given’s form 4 insider trades.
Insider Ownership Summary of Douglas B Given
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ARWR | Arrowhead Pharmaceuticals Inc | 2024-01-11 | director |
VIAP | VIA Pharmaceuticals Inc | 2010-11-15 | director |
AKSY | Aksys Ltd | 2006-10-06 | director |
Douglas B Given Latest Holdings Summary
Douglas B Given currently owns a total of 1 stock. Douglas B Given owns 129,711 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 11, 2024, with a value of $3 Million.
Latest Holdings of Douglas B Given
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ARWR | Arrowhead Pharmaceuticals Inc | 2024-01-11 | 129,711 | 23.78 | 3,084,528 |
Holding Weightings of Douglas B Given
Douglas B Given Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas B Given has made a total of 11 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 1 buys and 10 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 2,911 shares on January 11, 2024, which brought Douglas B Given around $110,793.
Insider Trading History of Douglas B Given
- 1
Douglas B Given Trading Performance
GuruFocus tracks the stock performance after each of Douglas B Given's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas B Given is -32.21%. GuruFocus also compares Douglas B Given's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas B Given within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Douglas B Given's insider trading performs compared to the benchmark.
Performance of Douglas B Given
Average Return
Outperforming Transactions
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | -24.17 | -32.21 | -50.85 | -43.14 | -31.5 | |
Relative Return to S&P 500(%) | -16.76 | -27.81 | -30.69 | -22.18 | -31.47 |
Douglas B Given Ownership Network
Ownership Network List of Douglas B Given
Ownership Network Relation of Douglas B Given
Douglas B Given Owned Company Details
What does Arrowhead Pharmaceuticals Inc do?
Who are the key executives at Arrowhead Pharmaceuticals Inc?
Douglas B Given is the director of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include other: Senior Vice President James C Hamilton , CFO Kenneth Allen Myszkowski , and director & President and CEO Christopher Richard Anzalone .
Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary
Over the past 18 months, Douglas B Given made 3 insider transaction in Arrowhead Pharmaceuticals Inc (ARWR) with a net sale of 10,286. Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 266,472 shares made by Christopher Richard Anzalone , a net sale of 79,524 shares made by James C Hamilton , and a net sale of 101,729 shares made by Kenneth Allen Myszkowski .
In summary, during the past 3 months, insiders sold 103,499 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 3,000 shares, with a net sale of 100,499 shares. During the past 18 months, 608,104 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 605,104 shares.
Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arrowhead Pharmaceuticals Inc Insider Transactions
Douglas B Given Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas B Given. You might contact Douglas B Given via mailing address: C/o Neorx Corp, 410 West Harrison St, Seattle Wa 98119.